Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
« Previous Article | Table of Contents | Next Article »
Arteriosclerosis, Thrombosis, and Vascular Biology. 1991;11:691-703

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Myant, N. B.
Right arrow Articles by Humphries, S. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Myant, N. B.
Right arrow Articles by Humphries, S. E.

Arteriosclerosis and Thrombosis, Vol 11, 691-703, Copyright © 1991 by American Heart Association

ARTICLES

Clinical signs of familial hypercholesterolemia in patients with familial defective apolipoprotein B-100 and normal low density lipoprotein receptor function

NB Myant, JJ Gallagher, BL Knight, SN McCarthy, J Frostegard, J Nilsson, A Hamsten, P Talmud and SE Humphries
MRC Lipoprotein Team, Hammersmith Hospital, London, England.

In a previous study (Tybjaerg-Hansen et al, Atherosclerosis 1990;80:235- 242), we identified nine patients heterozygous for the apolipoprotein B (apo B) arginine-to-glutamine (Arg3,500----Gln) mutation (familial defective apolipoprotein B-100 [FDB]). Six of these had been diagnosed clinically as familial hypercholesterolemic (FH) heterozygotes. We have since examined low density lipoprotein (LDL) receptor function in the FDB index patients and in three of their families. Skin fibroblasts from seven of seven unrelated FDB patients from whom cell lines were established exhibited normal high-affinity binding and degradation of normal LDL in vitro. In the three families, a raised plasma LDL concentration did not segregate with a haplotype of two polymorphic restriction sites at the LDL receptor locus. We conclude that the clinical and biochemical signs of classical FH can occur in the presence of the FDB mutation and a normal LDL receptor gene. In a four- generation family with 11 proven or presumed FDB heterozygotes, expression of the mutation ranged from normal plasma LDL concentrations and no clinical signs in two individuals, to hypercholesterolemia and death from myocardial infarction at age 31. Variable expression of the FDB mutation could not be explained conclusively by variation in diet, body mass index, smoking habit, apo E genotype, or plasma Lp(a) concentration.


This article has been cited by other articles:


Home page
 ANGIOLOGYHome page
J.-J. Li, M.-Z. Chen, and X. Chen
A Pedigree Analysis of Familial Hypercholesterolemia in Monozygote Twin Brothers
Angiology, November 1, 2003; 54(6): 711 - 713.
[Abstract] [PDF]

Home page
 Hum Mol GenetHome page
K. R. Wilund, M. Yi, F. Campagna, M. Arca, G. Zuliani, R. Fellin, Y.-K. Ho, J. V. Garcia, H. H. Hobbs, and J. C. Cohen
Molecular mechanisms of autosomal recessive hypercholesterolemia
Hum. Mol. Genet., November 15, 2002; 11(24): 3019 - 3030.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
C. Gagne, D. Gaudet, E. Bruckert, and for the Ezetimibe Study Group
Efficacy and Safety of Ezetimibe Coadministered With Atorvastatin or Simvastatin in Patients With Homozygous Familial Hypercholesterolemia
Circulation, May 28, 2002; 105(21): 2469 - 2475.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
B. Raungaard, F. Heath, P. S. Hansen, J. U. Brorholt-Petersen, H. K. Jensen, and O. Fargeman
Flow Cytometric Assessment of LDL Ligand Function for Detection of Heterozygous Familial Defective Apolipoprotein B-100
Clin. Chem., February 1, 2000; 46(2): 224 - 233.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
P.-c. Chan, A. Edwards, R. Lafrenière, and H. G. Parsons
Improved detection of familial hypercholesterolemia by determining low density lipoprotein receptor expression in mitogen-induced proliferating lymphocytes
J. Lipid Res., November 1, 1998; 39(11): 2261 - 2270.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
H. H.-J. Schmidt, M. Stuhrmann, R. Shamburek, C. K. Schewe, M. Ebhardt, L. A. Zech, C. Büttner, M. Wendt, U. Beisiegel, H. B. Brewer, et al.
Delayed Low Density Lipoprotein (LDL) Catabolism Despite a Functional Intact LDL-Apolipoprotein B Particle and LDL-Receptor in a Subject with Clinical Homozygous Familial Hypercholesterolemia
J. Clin. Endocrinol. Metab., June 1, 1998; 83(6): 2167 - 2174.
[Abstract] [Full Text]

Home page
 Clin. Chem.Home page
M.-L. Choong, E. S. C. Koay, K.-L. Khoo, M.-C. Khaw, and S. K. Sethi
Denaturing gradient-gel electrophoresis screening of familial defective apolipoprotein B-100 in a mixed Asian cohort: two cases of arginine3500 -> tryptophan mutation associated with a unique haplotype
Clin. Chem., June 1, 1997; 43(6): 916 - 923.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
A. R. Miserez and U. Keller
Differences in the Phenotypic Characteristics of Subjects With Familial Defective Apolipoprotein B-100 and Familial Hypercholesterolemia
Arterioscler Thromb Vasc Biol, October 1, 1995; 15(10): 1719 - 1729.
[Abstract] [Full Text]


ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search
Copyright © 1991 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited.